OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Showing 5 citing articles:
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García‐García
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
A comprehensive review of the multifaceted role of cannabinoid receptor type 2 in neurodegenerative and neuropsychiatric disorders
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access
María S. García‐Gutiérrez, Abraham B. Torregrosa, Francisco Navarrete, et al.
Pharmacological Research (2025) Vol. 213, pp. 107657-107657
Open Access
Monlunabant suppresses appetite through a central mechanism
Priya Mullassaril, Lucy Brodkin, Jesse Brodkin
Behavioural Pharmacology (2025)
Closed Access
Priya Mullassaril, Lucy Brodkin, Jesse Brodkin
Behavioural Pharmacology (2025)
Closed Access
Les antagonistes des récepteurs aux cannabinoïdes de type 1 (CB1) à action périphérique ont-ils un avenir dans le traitement de l’obésité et du diabète de type 2 ?
Océane Pointeau, Regina María Barbosa, Pascal Degrace, et al.
Médecine des Maladies Métaboliques (2024)
Open Access
Océane Pointeau, Regina María Barbosa, Pascal Degrace, et al.
Médecine des Maladies Métaboliques (2024)
Open Access
